Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/306% below fair value
$3.41−0.04 (-1.16%)
Close on Nov 12, 2026Market cap $1.26BP/E 20.1Yield –
Cronos profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cronos's profit margin for the twelve months ending Sep 30, 2026 was 28.0%. For fiscal 2025 it was -6.4%, against 34.9% the year before. The highest annual figure on record is 4911.6% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6.4% | −41.4 |
| FY2024 | Dec 31, 2024 | 34.9% | +119.7 |
| FY2023 | Dec 31, 2023 | -84.8% | +109.7 |
| FY2022 | Dec 31, 2022 | -194.5% | +419.0 |
| FY2021 | Dec 31, 2021 | -613.5% | −457.0 |
| FY2020 | Dec 31, 2020 | -156.5% | −5068.2 |
| FY2019 | Dec 31, 2019 | 4911.6% | +5090.1 |
| FY2018 | Dec 31, 2018 | -178.5% | −131.4 |
| FY2017 | Dec 31, 2017 | -47.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 21.8% | −49.7 |
| Q2 FY2026 | Jun 30, 2026 | 60.5% | +179.2 |
| Q1 FY2026 | Mar 31, 2026 | 30.4% | +11.4 |
| Q4 FY2025 | Dec 31, 2025 | -4.1% | −148.4 |
| Q3 FY2025 | Sep 30, 2025 | 71.4% | +47.1 |
| Q2 FY2025 | Jun 30, 2025 | -118.7% | −87.2 |
| Q1 FY2025 | Mar 31, 2025 | 19.0% | +27.8 |
| Q4 FY2024 | Dec 31, 2024 | 144.3% | +331.6 |
| Q3 FY2024 | Sep 30, 2024 | 24.4% | +31.0 |
| Q2 FY2024 | Jun 30, 2024 | -31.5% | +12.4 |
| Q1 FY2024 | Mar 31, 2024 | -8.9% | +89.5 |
| Q4 FY2023 | Dec 31, 2023 | -187.3% | +170.7 |
| Q3 FY2023 | Sep 30, 2023 | -6.6% | +174.6 |
| Q2 FY2023 | Jun 30, 2023 | -44.0% | +49.7 |
| Q1 FY2023 | Mar 31, 2023 | -98.3% | +32.1 |
| Q4 FY2022 | Dec 31, 2022 | -358.0% | +481.3 |
| Q3 FY2022 | Sep 30, 2022 | -181.2% | −563.1 |
| Q2 FY2022 | Jun 30, 2022 | -93.6% | +1052.7 |
| Q1 FY2022 | Mar 31, 2022 | -130.4% | +1148.8 |
| Q4 FY2021 | Dec 31, 2021 | -839.4% | −186.8 |
| Q3 FY2021 | Sep 30, 2021 | 381.8% | −226.0 |
| Q2 FY2021 | Jun 30, 2021 | -1146.3% | −63.9 |
| Q1 FY2021 | Mar 31, 2021 | -1279.1% | −2180.9 |
| Q4 FY2020 | Dec 31, 2020 | -652.5% | −1501.0 |
| Q3 FY2020 | Sep 30, 2020 | 607.8% | −9840.1 |
| Q2 FY2020 | Jun 30, 2020 | -1082.4% | −3512.8 |
| Q1 FY2020 | Mar 31, 2020 | 901.8% | −9554.0 |
| Q4 FY2019 | Dec 31, 2019 | 848.5% | – |
| Q3 FY2019 | Sep 30, 2019 | 10447.9% | – |
| Q2 FY2019 | Jun 30, 2019 | 2430.4% | – |
| Q1 FY2019 | Mar 31, 2019 | 10455.8% | – |
See a number that looks wrong?